AI-driven blood test uses epigenetic fingerprints to flag high-risk prediabetes
TL;DR
A German study shows that an AI-enhanced blood test analyzing DNA methylation markers can classify people into high- or moderate-risk prediabetes groups with about 90% accuracy, using 1,557 epigenetic markers to form a biological fingerprint. This approach could enable earlier, personalized prevention and reduce progression to type 2 diabetes, potentially serving as a simpler, cost-effective diagnostic tool compared with extensive clinical testing.
- Prediabetes: Blood test shows promise for earlier risk prediction Medical News Today
- AI tools could support people living with diabetes Pulse+IT News
- AI for Diabetes in the Community: Bringing Decision Support Beyond the Specialty Clinic Diabetes In Control
Want the full story? Read the original reporting
Read on Medical News Today